Effect of Peripheral Magnetic Stimulation in Patients With Chronic Lower Back Pain
Low Back Pain
Bottom Line
View on ClinicalTrials.gov: NCT07243548 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- rPMS Intervention (Device); rPMS Controle (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Inês Gomes
- Primary completion
- Nov 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Oswestry Disability Index (ODI) |
15.1; 15.0; 13.7; 4.6 | — |
| SECONDARY Pain Intensity at Rest (VAS) |
3.2; 3.4; 2.9; 2.0 | — |
| SECONDARY Pain Intensity During Activity (VAS) |
5.3; 5.4; 4.7; 2.8 | — |
| SECONDARY Pressure Pain Threshold Right Lumbar Region |
5600; 5700; 6100; 7500 | — |
| SECONDARY Pressure Pain Threshold Left Lumbar Region |
5300; 5400; 5900; 7300 | — |
| SECONDARY Lumbar Mobility (Schober Test) |
15.1; 15.0; 15.7; 16.5 | — |
| SECONDARY Oswestry Disability Category |
1.4; 1.3; 1.2; 0.5 | — |
| SECONDARY Physical Activity Level (IPAQ) |
0.5; 0.6; 0.5; 0.6 | — |
Summary
Eligibility Criteria
Inclusion Criteria
Individuals with complaints of low back pain for more than three months
Non-practitioners of sports activities
Absence of significant spinal pathologies, such as previous history of myelopathies, surgeries, instabilities, or deformities (bone fractures)
Normal neurological examination for radiculopathies (patellar and Achilles tendon reflexes, voluntary motor function, and sensitivity test)
Exclusion Criteria
Presence of trauma or systemic dysfunction
Use of other alternative treatments
Refusal to be randomized
Protrusion or prolapse of one or more intervertebral discs with neurological symptoms
Previous spinal surgery
Infectious spondylopathy
Low back pain secondary to inflammation, tumor, or autoimmune disease
Congenital spinal deformities
Compression fracture caused by osteoporosis, spondylolysis, or spondylolisthesis
Use of prosthesis
History of seizures or epilepsy
Implanted or non-removable intracranial metal or devices
Data sourced from ClinicalTrials.gov (NCT07243548). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.